[HTML][HTML] Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

X Mao, J Xu, W Wang, C Liang, J Hua, J Liu, B Zhang… - Molecular cancer, 2021 - Springer
Abstract Cancer-associated fibroblasts (CAFs), a stromal cell population with cell-of-origin,
phenotypic and functional heterogeneity, are the most essential components of the tumor …

[HTML][HTML] Interleukins in cancer: from biology to therapy

D Briukhovetska, J Dörr, S Endres, P Libby… - Nature Reviews …, 2021 - nature.com
Interleukins and associated cytokines serve as the means of communication for innate and
adaptive immune cells as well as non-immune cells and tissues. Thus, interleukins have a …

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

DE Johnson, RA O'Keefe, JR Grandis - Nature reviews Clinical …, 2018 - nature.com
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …

[HTML][HTML] The role of IL-6 in cancer cell invasiveness and metastasis—overview and therapeutic opportunities

M Rašková, L Lacina, Z Kejík, A Venhauerová… - Cells, 2022 - mdpi.com
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various
homeostatic and pathological processes. These activities range from regulating embryonic …

A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors

S Kaur, Y Bansal, R Kumar, G Bansal - Bioorganic & medicinal chemistry, 2020 - Elsevier
Abstract Interleukin-6 (IL-6) is a pleiotropic pro-inflammatory cytokine. Its deregulation is
associated with chronic inflammation, and multifactorial auto-immune disorders. It mediates …

Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach

M Aliyu, FT Zohora, AU Anka, K Ali, S Maleknia… - International …, 2022 - Elsevier
Several studies have shown that interleukin 6 (IL-6) is a multifunctional cytokine with both
pro-inflammatory and anti-inflammatory activity, depending on the immune response …

IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy

R Weber, C Groth, S Lasser, I Arkhypov, V Petrova… - Cellular …, 2021 - Elsevier
Myeloid-derived suppressor cells (MDSC) are generated during tumor progression and
suppress the anti-tumor functions of T and natural killer (NK) cells. Their enrichment is …

[HTML][HTML] Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Y Wang, KCC Johnson, ME Gatti-Mays, Z Li - Journal of hematology & …, 2022 - Springer
Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death-
ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable …

[HTML][HTML] Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy

TA Patente, MP Pinho, AA Oliveira… - Frontiers in …, 2019 - frontiersin.org
Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve
T cell activation and effector differentiation. They are, likewise, involved in the induction and …

Targeting the microenvironment in solid tumors

C Belli, D Trapani, G Viale, P D'Amico, BA Duso… - Cancer treatment …, 2018 - Elsevier
Tumorigenesis is a complex and dynamic process involving different cellular and non-
cellular elements composed of tumor microenvironment (TME). The interaction of TME with …